amylin glp 1 dual agonist Forget GLP-1: Wants to Be the Next Big Thing Upcoming wave of hormone-based therapies
Description
Association between therapy with dipeptidyl peptidase-4 (DPP-4) inhibitors and risk of ileus: a cohort study
Neuropeptide Y (NPY) produced in the brain stimulates stimulating appetite and slowing calorie burn
doi: 10.1016/j.psyneuen.2019.02.006
Unlike GIP, the action of GLP-1 is preserved in patients with type 2 diabetes
